Bloomberg Anywhere Remote Login Bloomberg Terminal Request a Demo

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


Last $129.68 USD
Change Today +1.60 / 1.25%
Volume 170.6K
BLUE On Other Exchanges
Symbol
Exchange
NASDAQ GS
Frankfurt
As of 11:21 AM 09/4/15 All times are local (Market data is delayed by at least 15 minutes).

Executive Profile*

Malcolm K. Brenner M.D., M.B., B.Chir., Ph.D., F.R.C.P., F.R.C.Path.

Member of Scientific Advisory Board,bluebird bio, Inc.
AgeTotal Calculated CompensationThis person is connected to 60 board members in 3 different organizations across 5 different industries.

See Board Relationships
----

Background*

Dr. Malcolm K. Brenner, MD, M.B., B.Chir., Ph.D., F.R.C.P., F.R.C.Path is a Professor of Medicine & Pediatrics and Director of Center for Cell and Gene Therapy at Baylor College of Medicine. Dr. Brenner served as Scientific & Medical Advisor of MaxCyte, Inc. He served as the President of the International Society of Hematotherapy and Graft Engineering and President-Elect of the American Society for Gene Therapy. From 1994 to 1997, he served as Director, Cell and Gene ...

Read Full Background

Corporate Headquarters*

150 Second Street
Cambridge, Massachusetts 02141

United States

Phone: 339-499-9300
Fax: --

Board Members Memberships*

There is no Board Members Memberships data available.

Education*

PhD 1981
University of Cambridge
BA 1972
University of Cambridge

Other Affiliations*

Annual Compensation*

There is no Annual Compensation data available.

Stock Options*

There is no Stock Options data available.

Total Compensation*

There is no Total Compensation data available.
*Data is at least as current as the most recent Definitive Proxy.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
BLUE:US $129.68 USD +1.60

COMPETITOR COMPENSATION

NamePosition/
Company
Compensation
Edward O. Lanphier IIFounder, Chief Executive Officer, President, Director and Member of Clinical Review Committee
Sangamo Biosciences Inc.
$650.0K
David M. Pernock Chairman, Chief Executive Officer and President
Fibrocell Science, Inc.
$490.0K
Compensation as of Fiscal Year 2014.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact BLUEBIRD BIO INC, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.